miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1/2 axis
Carcinogenesis · 2023
DOI: 10.1093/carcin/bgad037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2023. Verfasst von Lan Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China. Hauptthemen laut MEDLINE: MicroRNAs, Liver Neoplasms, Carcinoma, Hepatocellular, STAT1 Transcription Factor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Although emerging evidence has established the roles of miRNAs in hepatocellular carcinoma (HCC), the global functional implication of miRNAs in this malignancy remains largely uncharacterized. Here, we aim to systematically identify novel miRNAs involved in HCC and clarify the function and mechanism of specific novel candidate miRNA(s) in this malignancy. Through an integrative omics approach, we identified ten HCC-associated functional modules and a collection of candidate miRNAs. Among them, we demonstrated that miR-424-3p, exhibiting strong associations with extracellular matrix (ECM), promotes HCC cells migration and invasion in vitro and facilitates HCC metastasis in vivo. We further demonstrated that SRF is a direct functional target of miR-424-3p, and is required for the oncogenic activity of miR-424-3p. Finally, we found that miR-424-3p reduces the interferon pathway by attenuating the transactivation of SRF on STAT1/2 and IRF9 genes, which in turn enhances the matrix metalloproteinases (MMPs)-mediated ECM remodeling. This study provides comprehensive functional relevance of miRNAs in HCC by an integrative omics analysis, and further clarifies that miR-424-3p in ECM functional module plays an oncogenic role via reducing the SRF-STAT1/2 axis in this malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.
- State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences at Beijing, Beijing Institute of Lifeomics, Beijing, China.
- Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
- Key Laboratory of Carcinogenesis and Translational Research, Department I of Hepatopancreatobiliary Surgery, Cancer Hospital and Institute, Peking University, Beijing, China.
- Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China.
- Collaborative Innovation Center for Personalized Cancer Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Gangqiao Zhou
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Feng, L., Chen, X., Li, P., Li, Y., Zhai, Y., Liu, X., Jin, Q., Zhang, H., Yu, C., Xing, B., Cui, Y., Cao, P., & Zhou, G. (2023). miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1/2 axis. Carcinogenesis. https://doi.org/10.1093/carcin/bgad037
Vancouver
Feng L, Chen X, Li P, Li Y, Zhai Y, Liu X, et al. miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1/2 axis. Carcinogenesis. 2023. doi:10.1093/carcin/bgad037
BibTeX
@article{Feng2023,
author = {Feng, Lan and Chen, Xi and Li, Peiyao and Li, Yuanfeng and Zhai, Yun and Liu, Xinyi and Jin, Qian and Zhang, Hongxing and Yu, Chaohui and Xing, Baocai and Cui, Ying and Cao, Pengbo and Zhou, Gangqiao},
title = {miR-424-3p promotes metastasis of hepatocellular carcinoma via targeting the SRF-STAT1/2 axis},
journal = {Carcinogenesis},
year = {2023},
doi = {10.1093/carcin/bgad037}
}
EUVIMED